Last edition
News about "Pharma Exports by 2030, Biosimilars to Lead Growth"
India Eyes 1 Trillion USD Pharma Exports by 2030, Biosimilars to Lead Growth Surge
As reported by The Economic Times, Pharmexcil Chairman Namit Joshi projected that India’s biosimilars segment could exceed 60 billion USD in exports by 2030—accounting for nearly half of the estimated 120–130 billion USD in total pharma exports.
Pharma Exports By 2030, Biosimilars To Lead Growth | 15/07/2025 | By Darshana | 555
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members